Teva Says Phase III Study Of Lipegfilgrastim In Breast Cancer Met Primary Goal - RTT News Teva Says Phase III Study Of Lipegfilgrastim In Breast Cancer Met Primary GoalRTT NewsThe Phase III, multinational, randomized, double-blind controlled study was conducted in over 200 breast cancer patients receiving four cycles of chemotherapy. Patients were randomized to receive treatment with either 6mg
Langganan:
Posting Komentar (Atom)
0 komentar:
Posting Komentar